| For: | Xia Y, Hu Y, Ma JH. Premixed insulin: Advantages, disadvantages, and future. World J Diabetes 2025; 16(3): 102526 [PMID: 40093285 DOI: 10.4239/wjd.v16.i3.102526] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i3/102526.htm |
| Number | Citing Articles |
| 1 |
Miao Yu. iGlarLixi: A titrateable fixed‐ratio combination of basal insulin + GLP‐1 receptor agonist—An effective type 2 diabetes treatment option in China. Diabetes, Obesity and Metabolism 2025; 27(S10): 15 doi: 10.1111/dom.70192
|
| 2 |
Eveline M Anto, Adheena M, P. Jayamurthy. ER stress: A putative therapeutic target for diabetes mellitus. Biochemical and Biophysical Research Communications 2026; 818: 153773 doi: 10.1016/j.bbrc.2026.153773
|